-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Tq8mgbutTp1hmCX+FH9+qUFBkB2nmAi8tg8LBGXSqnEU1cpqmlhRFq/LOdjNaKg0 p79Pk5yrIkAp/smD98em7Q== 0001179110-08-019439.txt : 20081114 0001179110-08-019439.hdr.sgml : 20081114 20081114130143 ACCESSION NUMBER: 0001179110-08-019439 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081112 FILED AS OF DATE: 20081114 DATE AS OF CHANGE: 20081114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOGEN INC CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 128 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6179952506 MAIL ADDRESS: STREET 1: 128 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARTER DAVID WARREN CENTRAL INDEX KEY: 0001200931 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 081188997 BUSINESS ADDRESS: STREET 1: C/O CELL GENESYS, INC. STREET 2: 500 FORBES BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650 266 3000 MAIL ADDRESS: STREET 1: C/O CELL GENESYS, INC. STREET 2: 500 FORBES BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgar.xml FORM 4 - X0303 4 2008-11-12 0 0000855654 IMMUNOGEN INC IMGN 0001200931 CARTER DAVID WARREN 468 HOLLIS LANE ST. HELENA CA 94574 1 0 0 0 Deferred Share Unit 0 2008-11-12 4 A 0 8000 0 A 2009-02-12 Common Stock 8000 8000 D The deferred share units were issued pursuant to the Issuer's 2004 Non-Employee Director Compensation and Deferred Share Unit Plan, as amended, and are convertible into Common Stock on a one-to-one basis. The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors. The deferred share units vest ratably over a three year period in quarterly increments at the end of each quarter beginning on February 12, 2009. /s/ Craig Barrows, attorney in fact 2008-11-14 -----END PRIVACY-ENHANCED MESSAGE-----